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quantification. Moreover, the activation of hormone-sensitive lipase (HSL) and perilipins was determined by immunofluorescence and western-blotting (WB). Adipose triglyceride lipase (ATGL) implication on melanocortin-mediated lipolysis was observed by small interference RNA. Fatty acid biosynthesis was addressed by WB analysis of the phosphorylated state of acetyl-CoA carboxilase (ACC). Fatty acid re-esterification was measured by quantifying the activity of phosphoenolpyruvate carboxykinase (PEPCK). The role of MC5R on all these processes was evaluated by siRNA.
Results: a-MSH/MC5R role on lipid mobilization is mediated by HSL, ATGL and perilipins. Immunof luorescence microscopy of a-MSH-treated cells revealed that phosphorylated HSL clearly surrounds lipid droplets, in opposition to perilipins that leave the immediate periphery of lipids. These observations are lost in adipocytes with suppressed expression of MC5R. Moreover, a-MSH/MC5R decreases "de novo" synthesis of fatty acids through inactivation of ACC. Furthermore, fatty acid re-esterification is also impaired after a-MSH stimulation since a reduction on PEPCK activity was observed.
Conclusion: Altogether these results indicate that, in adipocytes, a-MSH-activated MC5R regulates three tightly coupled pathways: lipolysis, lipid synthesis and re-esterification. The global effect is a decrease on adipocyte fat mass, important in strategies contributing to ameliorate obesity.
This work was funded by SPEDM/ABBOTT and TANITA. Adriana R. Rodrigues was supported by FCT (SFRH/BD/41024/2007). Introduction: Adipose tissue dysfunction results from many factors, including glycation-induced microvascular damages. Pyridoxamine is a scavenger of free radical and carbonyl species, able to protect the biological systems under glycating conditions. In this work we tested the usefulness of pyridoxamine treatment in inhibiting methylglyoxal-induced glycation in adipose tissue.
CO062. PYRIDOXAMINE REDUCES THE MICROVASCULAR EFFECTS OF METHYLGLYOXAL-INDUCED GLYCATION IN ADIPOSE TISSUE
Methods: Wistar rats were treated daily with methylglyoxal (MG) during 8 weeks (75 mg/Kg/day, diluted in the water). After this time, half of the animals did not have any treatment (WM), while the other half (WMPyr) was treated during 4 weeks with pyridoxamine (1 g/day, diluted in water). Another group of Wistar rats with no treatment was used as control (W).
Results: WM group showed a decrease of HDL cholesterol and an increase of circulating free fatty acids, what was reverted by pyridoxamine (WMPyr group). MG also caused an increase of tissue levels of CEL (glycation marker) and TGF-beta precursor (pro fibrotic factor), as well as increased staining of PAS and Masson Trichrome-positive components. Pyridoxamine resulted in CEL and TGF-beta levels similar to W group and inhibited the accumulation of PAS and Masson Trichrome-positive components. MG caused a decrease of Bcl-2/Bax ratio (marker of apoptosis) and vWF staining (microvascular marker), what was partially reverted by the treatment with pyridoxamine.
Conclusion: Pyridoxamine prevents methylglyoxal-induced accumulation of glycated and fibrotic materials, what may result in better microvascular function in adipose tissue. Adiponectin (ApN) is the most abundant peptide secreted by adipocytes and has important effects on the cardiovascular and endocrine systems. It is involved in a wide variety of physiological processes including energy metabolism, inf lammation, and vascular physiology. Despite being made by adipocytes, circulating adiponectin levels are paradoxically decreased in obesity and metabolic syndrome. Thus, we investigated the effects of chronic administration of ApN on vascular reactivity (contraction and relaxation) of rat aorta and mesenteric arteries in 12-month-old male Wistar rats fed with high fat diet. The effects of ApN were investigated on NO-dependent and independent vasorelaxation in isolated rat aortic and mesenteric arteries from 12-month-old male Wistar rats fed with high fat diet during 4 months (WHF) and compared them with WHF and with Wistar control rats fed with standard diet (W). Adiponectin (2.7 mg) was administered by continuous infusion with a minipump implanted subcutaneously on the back for 28 days before sacrifice. High fat diet induced significantly increased body weight and an increment in systemic levels of leptin and leptin/adiponectin ratio. It also significantly reduced the efficacy of NO-dependent vasorelaxation both in aorta and mesenteric arteries. Chronic ApN treatment significantly reduced body weight, leptin levels and the leptin/adiponectin ratio, normalizing endothelial function in both arteries. These results indicate that high-fat diet induced endothelial dysfunction in normal Wistar rats and that ApN was able to normalize endothelial function by a mechanism that likely includes an increment in NO bioavailability. Detailed characterization of the ApN signaling pathway in the vasculature and perivascular fat (as well as other metabolic tissues) is likely to provide novel tools in the management of atherosclerosis and metabolic disease. 
CO063. VASOPROTECTIVE EFFECTS OF ADIPONECTIN IN HIGH-FAT FED WISTAR RATS

CO064. POTENCIAL TERAPÊUTICO
